nexgard combo
boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - cats - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. the veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.
nexgard combo- esafoxolaner, eprinomectin, and praziquantel solution
boehringer ingelheim animal health usa inc. - esafoxolaner (unii: 46658iqn7v) (esafoxolaner - unii:46658iqn7v), eprinomectin (unii: 75kp30fd8o) (eprinomectin - unii:75kp30fd8o), praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - nexgard® combo is indicated for the prevention of heartworm disease caused by dirofilaria immitis and for the treatment and control of roundworm (fourth stage larval and adult toxocara cati ), hookworm (fourth stage larval and adult ancylostoma tubaeforme ; adult ancylostoma braziliense ), and tapeworm (dipylidium caninum ) infections. nexgard® combo kills adult fleas (ctenocephalides felis ) and is indicated for the treatment and prevention of flea infestations and the treatment and control of ixodes scapularis (black-legged tick) and amblyomma americanum (lone star tick) infestations for one month in cats and kittens 8 weeks of age and older, and weighing 1.8 lbs or greater. there are no known contraindications for the use of nexgard® combo.
nexgard spectra spot-on solution for cats
boehringer ingelheim animal health new zealand limited - eprinomectin; praziquantel; esafoxolaner - eprinomectin 4 g/litre; praziquantel 83 g/litre; esafoxolaner 12 g/litre - endoparasiticide
nexgard spectra spot-on for cats 0.8 - 2.4 kg
boehringer ingelheim animal health australia pty. ltd. - eprinomectin; praziquantel; esafoxolaner - topical solution/suspension - eprinomectin active 4.0 g/l; praziquantel anthelmintic active 83.0 g/l; esafoxolaner active active 12.0 g/l - parasiticides
nexgard spectra spot-on for cats 2.5 - 7.5 kg
boehringer ingelheim animal health australia pty. ltd. - eprinomectin; praziquantel; esafoxolaner - topical solution/suspension - eprinomectin active 4.0 g/l; praziquantel anthelmintic active 83.0 g/l; esafoxolaner active active 12.0 g/l - parasiticides
nexgard combo (cats > 2.5 kg) 24.90 mg/3.60 mg/1.20 mg per 0.3 ml spot-on solution
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - praziquantel , esafoxolaner , eprinomectin (vet.) - spot-on solution - 24.90 mg/3.60 mg/1.20 mg per 0.3 ml
nexgard combo (cats 2.5-7.5 kg) 74.70 mg/10.80 mg/3.60 mg per 0.9 ml spot-on solution
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - praziquantel , esafoxolaner , eprinomectin (vet.) - spot-on solution - 74.70 mg/10.80 mg/3.60 mg per 0.9 ml
nexgard combo spot-on solution for cats <2.5kg
rhone ma malaysia sdn bhd - eprinomectin; praziquantel; esafoxolaner -
esafoxolaner
boehringer ingelheim animal health australia pty. ltd. - esafoxolaner - unknown - esafoxolaner active active 0.0 - active constituent
nexgard combo solution
boehringer ingelheim animal health canada inc. - esafoxolaner; eprinomectin; praziquantel - solution - 1.2%; 0.4%; 8.3% - esafoxolaner 1.2%; eprinomectin 0.4%; praziquantel 8.3% - cats